SKN.ASX: Trading Halt

Trading Halt

Stock	Skin Elements Ltd (SKN.ASX)
Release Time	13 Oct 2025, 9:33 a.m.
Price Sensitive	Yes

This feature provides summaries of price-sensitive announcements for companies followed by users on InvestorPA. The summaries are generated by large language models so please interpret with care.

Skin Elements Requests Trading Halt for Capital Raise

Key Points

Skin Elements (ASX: SKN) requests trading halt pending announcement of capital raise
Trading halt to remain in place until earlier of announcement or market open on 15 October 2025
Company not aware of any other information necessary to inform the market

Full Summary

Skin Elements Limited (ASX: SKN), an Australian owned and operated biotechnology healthcare company, has requested a trading halt in its securities with immediate effect. The trading halt has been requested pending an announcement by the company regarding a capital raise. In accordance with ASX Listing Rule 17.1, Skin Elements has stated that the trading halt will remain in place until the earlier of the making of an announcement or the commencement of trading on Wednesday, 15 October 2025. The company has confirmed that it is not aware of any other information necessary to inform the market about the trading halt, and that it is not aware of any reason why the trading halt should not be granted. The announcement has been authorised by the Board of Skin Elements Limited.